If the CONR stent sells for $2,000 (not the actual figure) and the delivery system is allocated 10% of the overall DES value, or $200, then $2-3 would be only a 1-1.5% royalty rate on the delivery system.
If $2-3 per unit is all SRDX is deriving from the CONR product, why even bother? That’s why I assumed he meant 2-3%, which would be roughly $4-6 per unit using the above numbers.
If I’m wrong and the yield is really only $2-3 per unit, CONR is going to have to sell a heck of a lot of units for this to amount to anything.
Market Data 
Markets 
AI
